「Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement<Abstract of dissertation>」の関連論文
-
TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
-
PBK expression predicts favorable survival in colorectal cancer patients
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
-
MDM4 as a prognostic factor for patients with gastric cancer with low expression of p53:immunohistochemical study of p53, MDM2, and MDM4
-
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation
-
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
-
Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma
-
Profiling of Naquotinib, a Small Molecule Kinase Inhibitor, as EGFR and BTK Inhibitor
-
Finding potential synergistic drugs to reduce chemo-resistance for the treatment of highly malignant tumors in female
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
An HSP90 inhibitor overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs
-
Intensity-modulated radiation therapy for lymph node oligo-recurrence
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
-
Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases
-
Elucidation of the role of αB-crystallin in malignant breast cancer
-
Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal
-
Low RAI2 expression is a marker of poor prognosis in breast cancer
-
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy
-
FE65 in breast cancer: its clinicopathological and biological significance
-
A never-ending FLT3 story
-
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
-
ヒト肺腺癌細胞A549におけるエンドセリン-2欠失による抗がん効果
-
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
-
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
-
Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
Progesterone Receptor isoform B exerts inhibitory effects on tumor cell proliferation regulated by let-7b in Progesterone receptor-positive non-small cell lung cancer
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Survival Analyses Based on Tumor Microenvironment Profile in Endometrial Carcinoma
-
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
-
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
-
Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer